Type I (sporadic) porphyria cutanea tarda in a hemodialysis patient: A case report

Hemodialysis International

Volumn 12, Issue SUPPL. 2, 2008, Pages

  Tarwater, Kurt ^a   Misra, Shamita ^a   Misra, Madhukar ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b Department of Internal Medicine   (United States)

Author keywords

Blisters; Hemodialysis; Porphyria cutanea tarda

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; HYDROXYCHLOROQUINE; IRON; LIVER ENZYME; PORPHYRIN;

ADULT; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DIALYSIS MEMBRANE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS C; HIRSUTISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; HYPERTENSION; IRON OVERLOAD; KIDNEY FAILURE; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PSEUDOPORPHYRIA; SKIN BIOPSY; TREATMENT RESPONSE;

ENZYME INHIBITORS; FEMALE; HEPATITIS C; HUMANS; HYDROXYCHLOROQUINE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; RENAL DIALYSIS;

EID: 53349160354     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00323.x     Document Type: Conference Paper

References (8)

1. McKane W, Green C, Farrington K. Porphyria cutanea tarda precipitated by intravenous iron in a haemodialysis patient. Nephrol Dial Transplant. 2001; 16:1936-1938.
2. Sinclair PR, Bement WJ, Bonkovsky HL, Sinclair JF. Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures: Essential role for induction of cytochrome P-448. Biochem J. 1984; 222:737-748.
3. Smith AG, Francis JE. Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload. Biochem J. 1987; 246:221-226.
4. Suarez M, Beloqui O, Ferrer J, et al. Glutation reducido linfocitazio y hepatitis cronica activa por virus C. Gastroenterol Hepatol. 1992; 15:272.
5. Bulaj ZJ, Phillips JD, Ajioka RS, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood. 2000; 95:1565-1571.
6. Carson R, Dunnigan E, et al. Removal of plasma prophyrins with high-flux hemodialysis in porphyria cutanea tarda associated with end-stage renal disease. J Am Soc Nephrol. 1992; 2:1445-1450.
7. McColl K, Simpson K, Laiwah AY, et al. Hemodialysis related porphyria cutanea tarda-Treatment failure with charcoal hemoperfusion. Photodermatol. 1986; 3:169-173.
8. Allen BR, Parker S, Thompson GG, Moore MR, Darby FJ, Hunter JA. The effect of treatment on plasma uroporphyrin levels in Cutaneous hepatic porphyria. Br J Dermatol. 1975; 93:37-42.